BIOMAT Database Logo BIOMAT Database Logo

Fatal agranulocytosis following therapy with "presidon" (3,3-diethyl-2,4-dioxotetrahydropyridine), a new sedative hypnotic agent. 1950

A H Covner, and S L Halpern

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias

Related Publications

A H Covner, and S L Halpern
Clinical evaluation of a new sedative-hypnotic (3,3-diethyl-2,4-dioxotetrahydropyridine) in psychiatric conditions.
January 1947, The Psychiatric quarterly,
A H Covner, and S L Halpern
Presidon; a new sedative-hypnotic.
April 1949, Christ Hospital medical bulletin,
A H Covner, and S L Halpern
Urinary excretion of 3,3-diethyl-2,4-dioxotetrahydropyridine in man.
December 1947, The American journal of the medical sciences,
A H Covner, and S L Halpern
Observations on the toxicity of 3,3-diethyl-2,4-diketotetrahydropyridine (presidon).
January 1951, Texas reports on biology and medicine,
A H Covner, and S L Halpern
Evaluation of a new sedative drug 3,3-diethyl-2,4-dioxopiperidine.
May 1948, The Journal of laboratory and clinical medicine,
A H Covner, and S L Halpern
Fatal hyperthermia following haloperidol therapy of sedative-hypnotic withdrawal.
August 1978, The Journal of clinical psychiatry,
A H Covner, and S L Halpern
[Experiences with a barbiturate-free hypnotic and sedative in small children. Clinical and electroencephalographic research on 2,4-dioxo-3,3-diethyl-5-methylpiperidine (Noludar)].
March 1962, Munchener medizinische Wochenschrift (1950),
A H Covner, and S L Halpern
The sedative-hypnotic properties of quazepam, a new hypnotic agent.
January 1982, Arzneimittel-Forschung,
A H Covner, and S L Halpern
Clinical studies on toxicity and on hypnotic and sedative effects of RO 1-6463*, noludar (3,3-diethyl-2,4-dioxo-5-methylpiperidine).
February 1955, International record of medicine and general practice clinics,
A H Covner, and S L Halpern
Neuropharmacological activity of new derivatives of 3,3-diethyl-2,4-pyridinedione. IV. 1-alkyl derivatives of 3,3-diethyl-2,4-pyridinedione.
January 1979, Acta physiologica et pharmacologica Bulgarica,
Copied contents to your clipboard!